Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR.

Identifieur interne : 000940 ( Ncbi/Merge ); précédent : 000939; suivant : 000941

Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR.

Auteurs : Laura Gillim-Ross [États-Unis] ; Jill Taylor ; David R. Scholl ; Jared Ridenour ; Paul S. Masters ; David E. Wentworth

Source :

RBID : pubmed:15243082

Descripteurs français

English descriptors

Abstract

The severe acute respiratory syndrome coronavirus (SARS-CoV) is the causative agent of the recent outbreak of severe acute respiratory syndrome. VeroE6 cells, fetal rhesus monkey kidney cells, and human peripheral blood mononuclear cells were the only cells known to be susceptible to SARS-CoV. We developed a multiplex reverse transcription-PCR assay to analyze the susceptibility of cells derived from a variety of tissues and species to SARS-CoV. Additionally, productive infection was determined by titration of cellular supernatants. Cells derived from three species of monkey were susceptible to SARS-CoV. However, the levels of SARS-CoV produced differed by 4 log(10). Mink lung epithelial cells (Mv1Lu) and R-Mix, a mixed monolayer of human lung-derived cells (A549) and mink lung-derived cells (Mv1Lu), are used by diagnostic laboratories to detect respiratory viruses (e.g., influenza virus); they were also infected with SARS-CoV, indicating that the practices of diagnostic laboratories should be examined to ensure appropriate biosafety precautions. Mv1Lu cells produce little SARS-CoV compared to that produced by VeroE6 cells, which indicates that they are a safer alternative for SARS-CoV diagnostics. Evaluation of cells permissive to other coronaviruses indicated that these cell types are not infected by SARS-CoV, providing additional evidence that SARS-CoV binds an alternative receptor. Analysis of human cells derived from lung, kidney, liver, and intestine led to the discovery that human cell lines were productively infected by SARS-CoV. This study identifies new cell lines that may be used for SARS-CoV diagnostics and/or basic research. Our data and other in vivo studies indicate that SARS-CoV has a wide host range, suggesting that the cellular receptor(s) utilized by SARS-CoV is highly conserved and is expressed by a variety of tissues.

DOI: 10.1128/JCM.42.7.3196-3206.2004
PubMed: 15243082

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:15243082

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR.</title>
<author>
<name sortKey="Gillim Ross, Laura" sort="Gillim Ross, Laura" uniqKey="Gillim Ross L" first="Laura" last="Gillim-Ross">Laura Gillim-Ross</name>
<affiliation wicri:level="2">
<nlm:affiliation>Wadsworth Center, New York State Department of Health, 120 New Scotland Ave., Albany, NY 12208, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Wadsworth Center, New York State Department of Health, 120 New Scotland Ave., Albany, NY 12208</wicri:regionArea>
<placeName>
<region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Taylor, Jill" sort="Taylor, Jill" uniqKey="Taylor J" first="Jill" last="Taylor">Jill Taylor</name>
</author>
<author>
<name sortKey="Scholl, David R" sort="Scholl, David R" uniqKey="Scholl D" first="David R" last="Scholl">David R. Scholl</name>
</author>
<author>
<name sortKey="Ridenour, Jared" sort="Ridenour, Jared" uniqKey="Ridenour J" first="Jared" last="Ridenour">Jared Ridenour</name>
</author>
<author>
<name sortKey="Masters, Paul S" sort="Masters, Paul S" uniqKey="Masters P" first="Paul S" last="Masters">Paul S. Masters</name>
</author>
<author>
<name sortKey="Wentworth, David E" sort="Wentworth, David E" uniqKey="Wentworth D" first="David E" last="Wentworth">David E. Wentworth</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15243082</idno>
<idno type="pmid">15243082</idno>
<idno type="doi">10.1128/JCM.42.7.3196-3206.2004</idno>
<idno type="wicri:Area/PubMed/Corpus">002C70</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002C70</idno>
<idno type="wicri:Area/PubMed/Curation">002C70</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002C70</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002D37</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002D37</idno>
<idno type="wicri:Area/Ncbi/Merge">000940</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR.</title>
<author>
<name sortKey="Gillim Ross, Laura" sort="Gillim Ross, Laura" uniqKey="Gillim Ross L" first="Laura" last="Gillim-Ross">Laura Gillim-Ross</name>
<affiliation wicri:level="2">
<nlm:affiliation>Wadsworth Center, New York State Department of Health, 120 New Scotland Ave., Albany, NY 12208, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Wadsworth Center, New York State Department of Health, 120 New Scotland Ave., Albany, NY 12208</wicri:regionArea>
<placeName>
<region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Taylor, Jill" sort="Taylor, Jill" uniqKey="Taylor J" first="Jill" last="Taylor">Jill Taylor</name>
</author>
<author>
<name sortKey="Scholl, David R" sort="Scholl, David R" uniqKey="Scholl D" first="David R" last="Scholl">David R. Scholl</name>
</author>
<author>
<name sortKey="Ridenour, Jared" sort="Ridenour, Jared" uniqKey="Ridenour J" first="Jared" last="Ridenour">Jared Ridenour</name>
</author>
<author>
<name sortKey="Masters, Paul S" sort="Masters, Paul S" uniqKey="Masters P" first="Paul S" last="Masters">Paul S. Masters</name>
</author>
<author>
<name sortKey="Wentworth, David E" sort="Wentworth, David E" uniqKey="Wentworth D" first="David E" last="Wentworth">David E. Wentworth</name>
</author>
</analytic>
<series>
<title level="j">Journal of clinical microbiology</title>
<idno type="ISSN">0095-1137</idno>
<imprint>
<date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>CD13 Antigens (physiology)</term>
<term>Cell Line</term>
<term>Haplorhini</term>
<term>Humans</term>
<term>Kidney (virology)</term>
<term>Receptors, Virus (analysis)</term>
<term>Reverse Transcriptase Polymerase Chain Reaction (methods)</term>
<term>SARS Virus (physiology)</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Haplorhini</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>RT-PCR ()</term>
<term>Rein (virologie)</term>
<term>Récepteurs viraux (analyse)</term>
<term>Réplication virale</term>
<term>Virus du SRAS (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Receptors, Virus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en">
<term>CD13 Antigens</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Récepteurs viraux</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Rein</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Kidney</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cell Line</term>
<term>Haplorhini</term>
<term>Humans</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Haplorhini</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>RT-PCR</term>
<term>Réplication virale</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The severe acute respiratory syndrome coronavirus (SARS-CoV) is the causative agent of the recent outbreak of severe acute respiratory syndrome. VeroE6 cells, fetal rhesus monkey kidney cells, and human peripheral blood mononuclear cells were the only cells known to be susceptible to SARS-CoV. We developed a multiplex reverse transcription-PCR assay to analyze the susceptibility of cells derived from a variety of tissues and species to SARS-CoV. Additionally, productive infection was determined by titration of cellular supernatants. Cells derived from three species of monkey were susceptible to SARS-CoV. However, the levels of SARS-CoV produced differed by 4 log(10). Mink lung epithelial cells (Mv1Lu) and R-Mix, a mixed monolayer of human lung-derived cells (A549) and mink lung-derived cells (Mv1Lu), are used by diagnostic laboratories to detect respiratory viruses (e.g., influenza virus); they were also infected with SARS-CoV, indicating that the practices of diagnostic laboratories should be examined to ensure appropriate biosafety precautions. Mv1Lu cells produce little SARS-CoV compared to that produced by VeroE6 cells, which indicates that they are a safer alternative for SARS-CoV diagnostics. Evaluation of cells permissive to other coronaviruses indicated that these cell types are not infected by SARS-CoV, providing additional evidence that SARS-CoV binds an alternative receptor. Analysis of human cells derived from lung, kidney, liver, and intestine led to the discovery that human cell lines were productively infected by SARS-CoV. This study identifies new cell lines that may be used for SARS-CoV diagnostics and/or basic research. Our data and other in vivo studies indicate that SARS-CoV has a wide host range, suggesting that the cellular receptor(s) utilized by SARS-CoV is highly conserved and is expressed by a variety of tissues.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">15243082</PMID>
<DateCompleted>
<Year>2004</Year>
<Month>08</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0095-1137</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>42</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2004</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Journal of clinical microbiology</Title>
<ISOAbbreviation>J. Clin. Microbiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR.</ArticleTitle>
<Pagination>
<MedlinePgn>3196-206</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The severe acute respiratory syndrome coronavirus (SARS-CoV) is the causative agent of the recent outbreak of severe acute respiratory syndrome. VeroE6 cells, fetal rhesus monkey kidney cells, and human peripheral blood mononuclear cells were the only cells known to be susceptible to SARS-CoV. We developed a multiplex reverse transcription-PCR assay to analyze the susceptibility of cells derived from a variety of tissues and species to SARS-CoV. Additionally, productive infection was determined by titration of cellular supernatants. Cells derived from three species of monkey were susceptible to SARS-CoV. However, the levels of SARS-CoV produced differed by 4 log(10). Mink lung epithelial cells (Mv1Lu) and R-Mix, a mixed monolayer of human lung-derived cells (A549) and mink lung-derived cells (Mv1Lu), are used by diagnostic laboratories to detect respiratory viruses (e.g., influenza virus); they were also infected with SARS-CoV, indicating that the practices of diagnostic laboratories should be examined to ensure appropriate biosafety precautions. Mv1Lu cells produce little SARS-CoV compared to that produced by VeroE6 cells, which indicates that they are a safer alternative for SARS-CoV diagnostics. Evaluation of cells permissive to other coronaviruses indicated that these cell types are not infected by SARS-CoV, providing additional evidence that SARS-CoV binds an alternative receptor. Analysis of human cells derived from lung, kidney, liver, and intestine led to the discovery that human cell lines were productively infected by SARS-CoV. This study identifies new cell lines that may be used for SARS-CoV diagnostics and/or basic research. Our data and other in vivo studies indicate that SARS-CoV has a wide host range, suggesting that the cellular receptor(s) utilized by SARS-CoV is highly conserved and is expressed by a variety of tissues.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gillim-Ross</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Wadsworth Center, New York State Department of Health, 120 New Scotland Ave., Albany, NY 12208, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taylor</LastName>
<ForeName>Jill</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Scholl</LastName>
<ForeName>David R</ForeName>
<Initials>DR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ridenour</LastName>
<ForeName>Jared</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Masters</LastName>
<ForeName>Paul S</ForeName>
<Initials>PS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wentworth</LastName>
<ForeName>David E</ForeName>
<Initials>DE</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>N01-A1-25490</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U901CCU216988-03</GrantID>
<Acronym>CC</Acronym>
<Agency>ODCDC CDC HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Clin Microbiol</MedlineTA>
<NlmUniqueID>7505564</NlmUniqueID>
<ISSNLinking>0095-1137</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C078034">coronavirus receptors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.11.2</RegistryNumber>
<NameOfSubstance UI="D018826">CD13 Antigens</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018826" MajorTopicYN="N">CD13 Antigens</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000882" MajorTopicYN="N">Haplorhini</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011991" MajorTopicYN="N">Receptors, Virus</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2004</Year>
<Month>7</Month>
<Day>10</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2004</Year>
<Month>8</Month>
<Day>20</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2004</Year>
<Month>7</Month>
<Day>10</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">15243082</ArticleId>
<ArticleId IdType="doi">10.1128/JCM.42.7.3196-3206.2004</ArticleId>
<ArticleId IdType="pii">42/7/3196</ArticleId>
<ArticleId IdType="pmc">PMC446305</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Nature. 2003 May 15;423(6937):240</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12748632</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2003 Dec;28(3):239-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14522061</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2003 May 30;300(5624):1399-404</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12730501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12781535</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 Jul 26;362(9380):263-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12892955</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2003 Sep;84(Pt 9):2305-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12917450</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Mol Biol. 2003 Aug 29;331(5):991-1004</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12927536</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2003 Oct;41(10):4521-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14532176</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2003 Oct 10;302(5643):276-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12958366</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 Oct 25;362(9393):1353-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14585636</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2003 Oct 30;425(6961):915</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14586458</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14647384</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 1987 Jan;68 ( Pt 1):47-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3027248</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1990 Aug;64(8):3817-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2164599</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1991 Dec;65(12):6881-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1719235</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1992 May;188(1):274-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1314455</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1992 Jun 4;357(6377):417-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1350661</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1992 Jun 4;357(6377):420-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1350662</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1992 Dec;66(12):7420-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1279203</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1996 Jun;70(6):4142-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8648757</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1996 Jul;70(7):4291-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8676451</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1996 Dec;70(12):8669-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8970993</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Cell Res. 1997 Feb 25;231(1):112-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9056417</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 1997 Nov;78 ( Pt 11):2795-802</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9367365</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1997 Dec;71(12):9499-507</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9371612</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Biochem Sci. 1998 Nov;23(11):444-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9852764</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1999 Jan;73(1):638-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9847369</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunol Today. 1999 Feb;20(2):83-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10098327</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1999 Nov 25;264(2):398-409</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10562501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2001 Feb;82(Pt 2):385-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11161278</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2001 Oct;75(20):9741-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11559807</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12711465</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1995-2005</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12671061</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Chem. 2003 Jun;49(6 Pt 1):953-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12765993</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>État de New York</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Masters, Paul S" sort="Masters, Paul S" uniqKey="Masters P" first="Paul S" last="Masters">Paul S. Masters</name>
<name sortKey="Ridenour, Jared" sort="Ridenour, Jared" uniqKey="Ridenour J" first="Jared" last="Ridenour">Jared Ridenour</name>
<name sortKey="Scholl, David R" sort="Scholl, David R" uniqKey="Scholl D" first="David R" last="Scholl">David R. Scholl</name>
<name sortKey="Taylor, Jill" sort="Taylor, Jill" uniqKey="Taylor J" first="Jill" last="Taylor">Jill Taylor</name>
<name sortKey="Wentworth, David E" sort="Wentworth, David E" uniqKey="Wentworth D" first="David E" last="Wentworth">David E. Wentworth</name>
</noCountry>
<country name="États-Unis">
<region name="État de New York">
<name sortKey="Gillim Ross, Laura" sort="Gillim Ross, Laura" uniqKey="Gillim Ross L" first="Laura" last="Gillim-Ross">Laura Gillim-Ross</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000940 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000940 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:15243082
   |texte=   Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:15243082" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021